Iqvia builds on its strategic collaboration with argenx to provide safety systems and services

Research triangle park, n.c.--(business wire)--iqvia™ (nyse:iqv), a leading global provider of advanced analytics, technology solutions and clinical research services to the life sciences industry, today announced a strategic collaboration with argenx to advance treatment to patients with rare autoimmune diseases through innovative and integrated technology-enabled pharmacovigilance (pv) safety services and solutions. iqvia's integrated pv services and technology platforms will support argenx t.
IQV Ratings Summary
IQV Quant Ranking